Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Cadiz – page 6

82 clinical trials in Cadiz, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Cadiz at a glance
82
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

82 trials in Cadiz

Open in trial search

Multiple sclerosis+2

Not recruiting

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Methylprednisolone
  • Sponsor:F. Hoffmann-La Roche AG

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Janssen Cilag International

Migraine+1

Not recruiting

Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Axatilimab
  • Sponsor:Syndax Pharmaceuticals Inc.

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen Cilag International

Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen Cilag International

Sepsis+1

Not recruiting

Study on Noradrenaline and Terlipressin for Treating Septic Shock in Patients

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Terlipressin Acetate
  • Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla

Study of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen Cilag International

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Charcoal, Activated
  • Sponsor:Novartis Pharma AG

Ulcerative keratitis

Not recruiting

Study on Allogenic Stem Cells and Amniotic Membrane for Patients with Advanced Corneal Ulcers Unresponsive to Standard Treatment

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Allogenic Corneal-Derived Adult Keratocytes, Ex-Vivo Expanded
  • Sponsor:Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud

Pseudomonas infection

Not recruiting

Study on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin
  • Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla

Study on the Effects of Metoprolol, Prasugrel, and Carbasalate Calcium in Patients with Spontaneous Coronary Artery Dissection

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atenolol
  • Sponsor:Spanish Society Of Cardiology

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Cadiz

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on bladder cancer treatments, including studies of mitomycin C delivery and immunotherapy approaches. Research extends to pancreatic adenocarcinoma and triple-negative breast cancer, evaluating new therapeutic combinations.

  • Non-muscle invasive bladder cancer treatments
  • Neoadjuvant therapy for pancreatic cancer
  • Immunotherapy combinations

Studies are exploring both localized and advanced disease states with emphasis on improving survival rates.

02 Immunology and Allergies

Groundbreaking research in allergic conditions and autoimmune disorders, including studies on hidradenitis suppurativa and innovative immunotherapy approaches for allergic rhinitis.

  • Allergen-specific immunotherapy
  • Inflammatory skin conditions
  • Respiratory allergies

Trials aim to evaluate novel therapeutic agents and treatment protocols for chronic conditions.

03 Transplant Medicine

Studies focusing on improving outcomes in kidney transplantation, particularly addressing delayed graft function through innovative therapeutic approaches.

  • Prevention of graft rejection
  • Post-transplant complications
  • Novel immunosuppressive strategies

Research aims to enhance transplant success rates and reduce post-operative complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.